Healthcare provider profile · identity verified

Brian G Accola, M.D.

Family Practice · FAIRBANKS, AK · NPI 1447236823

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	617	164
Lisinopril	Lisinopril	512	138
Amlodipine Besylate	Amlodipine Besylate	428	117
Rosuvastatin Calcium	Rosuvastatin Calcium	317	97
Levothyroxine Sodium	Levothyroxine Sodium	293	78
Losartan Potassium	Losartan Potassium	257	74
Metoprolol Succinate	Metoprolol Succinate	223	63
Famotidine	Famotidine	204	60
Gabapentin	Gabapentin	191	45
Hydrochlorothiazide	Hydrochlorothiazide	185	53
Tamsulosin Hcl	Tamsulosin Hcl	172	57
Eliquis	Apixaban	168	40
Pantoprazole Sodium	Pantoprazole Sodium	156	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	142	21
Omeprazole	Omeprazole	137	38
Albuterol Sulfate Hfa	Albuterol Sulfate	136	53
Simvastatin	Simvastatin	130	28
Quetiapine Fumarate	Quetiapine Fumarate	120	suppressed
Carvedilol	Carvedilol	108	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	106	13
Alprazolam	Alprazolam	104	18
Allopurinol	Allopurinol	99	32
Furosemide	Furosemide	93	29
Metformin Hcl	Metformin Hcl	90	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	22
Escitalopram Oxalate	Escitalopram Oxalate	88	24
Pregabalin	Pregabalin	88	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	20
Pravastatin Sodium	Pravastatin Sodium	83	18
Zolpidem Tartrate	Zolpidem Tartrate	81	19
Mounjaro	Tirzepatide	79	13
Trazodone Hcl	Trazodone Hcl	76	17
Mirtazapine	Mirtazapine	74	18
Prednisone	Prednisone	64	26
Rybelsus	Semaglutide	63	17
Potassium Chloride	Potassium Chloride	62	21
Jardiance	Empagliflozin	60	20
Celecoxib	Celecoxib	59	20
Fluticasone Propionate	Fluticasone Propionate	59	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	16
Clopidogrel	Clopidogrel Bisulfate	57	14
Valsartan	Valsartan	56	16
Ezetimibe	Ezetimibe	55	17
Oxycodone Hcl	Oxycodone Hcl	53	suppressed
Tizanidine Hcl	Tizanidine Hcl	53	15
Topiramate	Topiramate	53	suppressed
Meloxicam	Meloxicam	51	12
Sertraline Hcl	Sertraline Hcl	51	13
Aripiprazole	Aripiprazole	50	suppressed
Finasteride	Finasteride	49	15
Montelukast Sodium	Montelukast Sodium	49	15
Chlorthalidone	Chlorthalidone	48	14
Clonazepam	Clonazepam	47	12
Divalproex Sodium	Divalproex Sodium	47	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	14
Xarelto	Rivaroxaban	44	15
Diazepam	Diazepam	42	12
Nitroglycerin	Nitroglycerin	42	21
Benztropine Mesylate	Benztropine Mesylate	41	suppressed
Ipratropium Bromide	Ipratropium Bromide	41	26
Ozempic	Semaglutide	41	suppressed
Glipizide Er	Glipizide	40	12
Irbesartan	Irbesartan	40	12
Valacyclovir	Valacyclovir Hcl	40	18
Alendronate Sodium	Alendronate Sodium	39	12
Lorazepam	Lorazepam	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Ibuprofen	Ibuprofen	38	13
Januvia	Sitagliptin Phosphate	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Spironolactone	Spironolactone	37	11
Triamcinolone Acetonide	Triamcinolone Acetonide	37	28
Myrbetriq	Mirabegron	34	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	33	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	32	suppressed
Colchicine	Colchicine	32	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	11
Lidocaine	Lidocaine	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	11
Baclofen	Baclofen	31	suppressed
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Premarin	Estrogens, Conjugated	30	11
Tramadol Hcl	Tramadol Hcl	30	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Mometasone Furoate	Mometasone Furoate	29	26
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Ketoconazole	Ketoconazole	25	12
Methadone Hcl	Methadone Hcl	25	suppressed
Nystatin	Nystatin	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Estradiol	Estradiol	23	11
Lamotrigine	Lamotrigine	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Sucralfate	Sucralfate	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Armour Thyroid	Thyroid,pork	20	suppressed
Atenolol	Atenolol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Loperamide	Loperamide Hcl	19	suppressed
Metronidazole	Metronidazole	19	13
Bupropion Xl	Bupropion Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Epinephrine	Epinephrine	17	14
Warfarin Sodium	Warfarin Sodium	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Clobazam	Clobazam	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Methylphenidate Er	Methylphenidate Hcl	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Naproxen	Naproxen	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ramipril	Ramipril	13	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Ubrelvy	Ubrogepant	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error